TransCode Therapeutics, Inc. (RNAZ)
USD 0.28
(-22.27%)
USD 0.28
(-22.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 516.74 Thousand | 98.6 Thousand | 42.47 Thousand | - | - | - |
| Gross Profit | -516.74 Thousand | -98.6 Thousand | -42.47 Thousand | - | - | - |
| Operating Expenses | 19.41 Million | 17.58 Million | 5.87 Million | 726.6 Thousand | 456.86 Thousand | 384.51 Thousand |
| Selling, General and Administrative Expenses | 6.63 Million | 8.43 Million | 3.39 Million | 442.14 Thousand | 230.55 Thousand | 301.46 Thousand |
| Research and Development Expenses | 12.26 Million | 10.23 Million | 2.75 Million | 284.45 Thousand | 226.3 Thousand | 82.53 Thousand |
| Other Expenses | - | -1.08 Million | -278.33 Thousand | - | - | - |
| Cost and Expenses | 19.41 Million | 17.58 Million | 5.87 Million | 726.6 Thousand | 456.86 Thousand | 384.51 Thousand |
| Operating Income | -19.41 Million | -18.66 Million | -6.15 Million | -726.6 Thousand | -456.86 Thousand | -383.99 Thousand |
| Interest Expense | 50.61 Thousand | 17.56 Million | 95.07 Thousand | 394.57 Thousand | 156.96 Thousand | - |
| Income Tax Expense | - | 17.56 Million | 95.07 Thousand | 394.43 Thousand | 156.93 Thousand | -69.44 Thousand |
| Earnings before Tax | -18.54 Million | -17.56 Million | -6.84 Million | -2.34 Million | -607.21 Thousand | -453.44 Thousand |
| Net Income | -18.54 Million | -35.12 Million | -6.93 Million | -2.73 Million | -764.14 Thousand | -453.44 Thousand |
| Earnings Per Share Basic | -103.61 | -2195.62 | -658.80 | -343.19 | -119.27 | -70.77 |
| Earnings Per Share Diluted | -103.61 | -2165.57 | -658.80 | -343.19 | -119.27 | -70.77 |
| Weighted Average Shares Outstanding | 179 Thousand | 16 Thousand | 10.53 Thousand | 7979.00 | 6407.00 | 6407.00 |
| Weighted Average Shares Outstanding (Diluted) | 179 Thousand | 16.22 Thousand | 10.53 Thousand | 7979.00 | 6407.00 | 6407.00 |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -17.97 Million | -17.46 Million | -6.1 Million | - | - | -69.44 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 753.14 Thousand | - | - |
| Cost of Revenue | 142.83 Thousand | 141.64 Thousand | 516.74 Thousand | 140.17 Thousand | 138.78 Thousand | 137.59 Thousand |
| Gross Profit | -142.83 Thousand | -141.64 Thousand | -516.74 Thousand | 612.97 Thousand | -138.78 Thousand | -137.59 Thousand |
| Operating Expenses | 4.97 Million | 3.28 Million | 18.9 Million | 3.91 Million | 5.3 Million | 4.34 Million |
| Selling, General and Administrative Expenses | 1.92 Million | 1.52 Million | - | 555.23 Thousand | 1.98 Million | 2.16 Million |
| Research and Development Expenses | 3.04 Million | 1.75 Million | - | 3.36 Million | 3.34 Million | 2.96 Million |
| Other Expenses | - | - | - | 79.4 Thousand | - | - |
| Cost and Expenses | 5.11 Million | 3.28 Million | 19.41 Million | 4.05 Million | 5.3 Million | 4.34 Million |
| Operating Income | -5.11 Million | -3.32 Million | -19.41 Million | -4.05 Million | -5.32 Million | -5.13 Million |
| Interest Expense | 4482.00 | -9706.00 | -55.89 Million | 55.89 Thousand | - | - |
| Income Tax Expense | -5.00 | -179.47 Thousand | 4.00 | -3.00 | 27.44 Thousand | 788.93 Thousand |
| Earnings before Tax | -5.19 Million | -3.32 Million | -18.54 Million | -4.08 Million | -5.29 Million | -4.34 Million |
| Net Income | -5.19 Million | -3.32 Million | -18.54 Million | -4.08 Million | -5.29 Million | -4.34 Million |
| Earnings Per Share Basic | -0.74 | -0.65 | - | -22.83 | -67.95 | -135.68 |
| Earnings Per Share Diluted | -0.74 | -0.65 | - | -22.83 | -67.15 | -131.61 |
| Weighted Average Shares Outstanding | 7.05 Million | 5.14 Million | 179 Thousand | 179 Thousand | 78 Thousand | 32 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 7.05 Million | 5.14 Million | 179 Thousand | 179 Thousand | 78.93 Thousand | 32.98 Thousand |
| Gross Margin | - | - | - | 0.81 | - | - |
| EBIT Margin | - | - | - | -5.20 | - | - |
| Profit Margin | - | - | - | -5.43 | - | - |
| EBITDA | -4.97 Million | -3.32 Million | - | -3.91 Million | -5.16 Million | -4.2 Million |
| Earnings Before Tax Margin | - | - | - | -5.39 | - | - |
QIIK
SADHNANIQ
QC7
300062
INDES
VML